COVID-19
August 15, 2022
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron[...]
September 18, 2020
September 18, 2020
September 16, 2020
September 15, 2020
September 14, 2020
September 11, 2020
September 9, 2020
September 8, 2020
September 8, 2020
September 6, 2020
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community